Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
136.00    0.80 (0.59%)
Bid:
136.00
Ask:
136.20
Spread: 0.20 (0.147%)
Market Cap: £278.93m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Director/PDMR Shareholding

21 May 2024 09:00

RNS Number : 1461P
Forterra plc
21 May 2024
 

21 May 2024

Forterra plc (the "Company")

Director / PDMR Shareholdings

Further to the maturity of the Forterra 2020 Save As You Earn Scheme (SAYE) on 1 December 2023, on 16 May 2024 the Company was notified by the scheme's administrators, Link Group, of the following PDMR transaction. The PDMR listed below exercised options over the share capital of the Company as follows:

Name

Role

Status

No. of options exercised

Exercise Price

Beneficial interest

% of ISC

Ben Guyatt

Director

PDMR

12,080

£1.49

113,722

< 1%

The exercise price of £1.49 was set upon the launch of the scheme in 2020 in line with HMRC rules. 

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Frances Tock (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

George Stewart

2.

Reason for the notification

a)

Position/status

PDMR (Strategy and Development Director)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Exercise of share options with an exercise price of £1.35p under the Forterra SAYE scheme

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 Purchase

£1.49

 

 

12,080 options maturing

 

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Purchase

£1.49

12,080

£17,999.20

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUUWAUPCGWU
Date   Source Headline
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research
24th Nov 20207:00 amRNSTrading Statement
5th Nov 20205:09 pmRNSHolding(s) in Company
9th Oct 20203:45 pmRNSGrant of Options under 2020 SAYE Scheme
18th Sep 202010:12 amRNSGrant under Performance Share Plan
18th Sep 20209:40 amRNSHolding(s) in Company
14th Sep 20201:50 pmRNSProgressive publishes new research
14th Sep 20209:05 amRNSHolding(s) in Company
10th Sep 20207:00 amRNS2020 HALF YEAR RESULTS
7th Sep 20205:34 pmRNSHolding(s) in Company
14th Aug 20201:45 pmRNSHolding(s) in Company
30th Jul 20204:54 pmRNSHolding(s) in Company
16th Jul 202010:09 amRNSHolding(s) in Company
8th Jul 20203:02 pmRNSHolding(s) in Company
8th Jul 202010:32 amRNSHolding(s) in Company
7th Jul 20203:27 pmRNSHolding(s) in Company
7th Jul 20203:25 pmRNSHolding(s) in Company
7th Jul 20202:20 pmRNSTotal Voting Rights and Capital
7th Jul 202012:44 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHolding(s) in Company
6th Jul 20203:34 pmRNSDirector Shareholdings
6th Jul 20203:32 pmRNSPCA Shareholdings
2nd Jul 20207:00 amRNSResults of Placing
1st Jul 20204:41 pmRNSProposed placing of new ordinary shares
1st Jul 20204:40 pmRNSFinancing update and proposed equity placing
25th Jun 202010:44 amRNSHolding(s) in Company
24th Jun 20208:02 amRNSHolding(s) in Company
22nd Jun 20203:27 pmRNSHolding(s) in Company
16th Jun 20207:55 amRNSHolding(s) in Company
10th Jun 202012:53 pmRNSHolding(s) in Company
10th Jun 202012:45 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSTrading Update
26th May 20202:25 pmRNSDirector/PDMR Shareholding
14th May 20201:45 pmRNSResult of AGM
14th May 202012:08 pmRNSSecond Price Monitoring Extn
14th May 202012:02 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSRecommencement of operations
16th Apr 202012:07 pmRNSSecond Price Monitoring Extn
16th Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 20207:00 amRNSAnnual Report 2019 and AGM 2020
26th Mar 20209:07 amRNSHolding(s) in Company
24th Mar 20202:50 pmRNSUpdate on Covid-19
24th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20205:41 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.